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ABSTRACT OF THE THESIS
ANALYSIS AND PROPERTIES OF
CAROTENOIDS IN VIVO AND IN VITRO
by
Yisi Cao
Florida International University, 2007
Miami, Florida
Professor John T. Landrum, Major Professor
The purpose of this study was to develop a deeper understanding of the nature of
carotenoid metabolism in the human and primate retina. We have sought to do this from
two perspectives (1) through preparation and study of a carotenoid diketone that is a
candidate metabolic product and (2) through measurement of the carotenoid distribution
in the retinas of neonatal macaques.
In this thesis we report the synthesis, purification, and characterization of the
product using HPLC, UV/Vis, MS, 1H-NMR. The data obtained are all consistent with
the proposed p,P-carotene-3,3'-dione.
There has been no thorough study of the development of the macular pigment during
the earliest stages of life immediately following birth. In this study 30 macaque retinas
ranging from 148 days of gestation to 15 years in age were analyzed. The amounts of the
carotenoids, lutein, R,R-zeaxanthin, and meso-zeaxanthin were determined using C 18
reversed-phase column and chiral, normal-phase column HPLC.
v
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Chapter I INTRODUCTION
Carotenoids are one class natural pigments and are widely found in many fruits,
vegetables, and flowers,' including oranges, pineapples, carrots, tomatoes, sunflowers,
and orchids. Many animals also have carotenoids in their skin, feathers, serum, fatty
tissue, or retinas. Examples of animals that are noted for their carotenoid coloration
include birds, insects, fish, and crustaceans. Although carotenoids are most often
associated with higher plants and animals, they are also commonly found in
microorganisms, such as algae and bacteria. Somewhat more than 600 different
carotenoids have been isolated from nature sources. Each year new carotenoids are
identified.3 4 Carotenoids can be synthesized in nature only by higher plants, algae, and
microorganisms. Although animals are incapable of synthesizing carotenoids, they obtain
carotenoids in their diet. About 50 different carotenoids are known to be absorbed from
the diet and metabolized by humans. 5
1. Structure and Properties
Carotenoids are defined by their chemical structures. The majority of carotenoids
are comprised from a 40-carbon isoprenoid structure, which can be considered the
skeleton of the molecule. Lycopene which is formed biosynthetically from phytoene is
the precursor to virtually all of the common C40 carotenoids, Figure 1.1. The C9 end-
groups of carotenoids may have several different structures. The end-groups may be
acyclic C9 alkenes, e.g. lycopene. Also it can be terminated by the cyclic end-groups
containing C5 or C6 rings and these may be elaborated with oxygen-containing functional
groups. End-groups of carotenoids are typically 6-membered rings. p-carotene, shown
below, Figure 1.2, is generally considered representative of the carotenoid family
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possessing C6 end-group rings. P-carotene was 2 P-rings but carotenoids with F- and 7-
ring structures are also known, see Figure 1.3. These different kinds of end-group
cyclization are now known to be carried out by different enzymes. Both lycopene P-
cyclase and lycopene E-cyclase are important examples, see Figure 1.3.6 But there is no
report of biochemical studies on the formation of the (6S)-y end group.6 The oxygen-
containing carotenoids can be alcohols, aldehydes, or ketones. Lycopene, p-carotene, and
the xanthophylls, zeaxanthin and lutein, are the most abundant and characteristic
carotenoids found in animals because of their high concentrations in common dietary
plants.'''
9
Figure 1.1 The structure of lycopene
Figure 1.2 The structure of P,P-Carotene
2
/Hc
H+ + Hb
Ha
c-End group y-End group 3-End group
Figure 1.3 The general scheme process the end-group cyclizations of carotenoids
The hydrocarbon carotenoids are known as carotenes, while carotenes which
contain one or more polar functional groups are named xanthophylls. Lutein and
zeaxanthin, the major yellow pigments in higher plants, are the most common
xanthophylls found in nature. Lutein and zeaxanthin are central to the body of research to
be described here. Their structures are seen in Figures 1.4 and 1.5. Lutein is a
micronutrient, and is found in many fruits and vegetables in our diet. Zeaxanthin is a
yellow pigment and is widespread in nature. It occurs in maize, algae, and bacteria.4 Both
of them are abundant carotenoids found in the animals.
18' OH
16 7 19 20 416 175' 3'
7 11 15 14' 12' 10' 8' 6' 2'
2 6 9\3 13' 
9 '
8 10 12 14 15' H' 7'
H O 8 
20' 19' 17' 16
Figure 1.4 The structure of zeaxanthin, 3,3'-dihydroxy-p, P-carotene, processes the same
end-group ring type
3
\\ 15 4 ' 2 ' 1 9 ' 6' I 6
HO l s
Figure 1.5 The structure of lutein, 3,3'-dihydroxy-P,c-carotene, processes 2 different end-
group ring types
Lutein and zeaxanthin are dihydroxy-carotenoids which possess 2 ionone rings
that are substituted at the 3- and 3'- carbons. Lutein and zeaxanthin are constitutional
isomers and the only difference is based on the position of the double bond in one of the
ionone rings. Zeaxanthin has Pp end-groups while lutein has one P-ring and one s-ring.
The 3- and 3'-carbons of the ionone rings are stereocenters and both lutein and
zeaxanthin exist in multiple stereoisomeric forms.
In zeaxanthin, Figure 1.5, the ionone rings are both P rings. The 3-ionone ring
double bond is placed between the C5 and C6 carbons. The ionone ring systems are
substituted by hydroxyl groups at 3- and 3'- carbons. Zeaxanthin possesses two
stereocenters and consequently three stereoisomers exist; all three occur in nature."
They are 3R,3'R-,f-carotene-3,3'-diol (RRZ), 3R,3'S-P,P-carotene-3,3'-diol (RSZ), and
3S,3'S-P,P-carotene-3,3'-diol (SSZ), see Figure 1.6. The configuration of RRZ is found
in most common animals and higher plants.'0 In the retina, RRS and RSZ are present in
nearly equal amounts. SSZ is also present, but at very low levels.' 2
4
OH
HO
(3R,3'R)-p,p-carotene-3,3'-diol
OH
(3R,3'S)-Pp -carotene-3,3'-diol
(3S,3'S)-P,p 
-carotene-3,3'-diol
Figure 1.6 These chemical structures show 3 zeaxanthin stereoisomers
Lutein, see Figure 1.5, has a P-ionone ring and an s-ionone ring. The presence of
the hydroxyl groups on the 3- and 3'- carbons in lutein gives similar physical properties
to zeaxanthin. The double bond from c-ionone ring is placed on C4 and C5 and the 3'-
hydroxyl group is allylic.' 3 Lutein has three stereocenters and it is capable of forming 8
isomers, see Figure 1.7.14 However, only a single lutein stereoisomer, (3R,3'R,6'R)-p,E-
carotene-3,3'-diol (1), is present in most higher plants. Lactucaxanthin and epilutein are
present in a few species but are not major dietary carotenoids.14
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H *OH
HO (3R,3'R,6'R) Lutein (1)
(3R,3'R,6'R)-3,3'-dihydroxy-p,e-carotene
H OH
HO
HO (3R,3'R,6'S) Lutein (2)
(3R,3'R,6'S)-3,3'-dihydroxy-3,E-carotene
H / OH
HO (3R,3'S,6'R) Lutein (3)
(3R,3'S,6'R)-3,3'-dihydroxy- -,E-carotene
H OH
HOH
H O (3 R,3'S,6'S) L ute in (4)
(3R,3'S,6'S)-3,3'-dihydroxy-3,E-carotene
H .,O H
HO \ (3S,3'R,6'R) Lutein (5)
(3 S,3'R,6'R)-3,3'-dihydroxy-p,E-carotene H OH
H
HO (3 S,3'R,6'S) Lutein (6)
(3 S,3'R,6'S)-3,3'-dihydroxy-3,E-carotene
H ,0H
HO" (3 S,3'S,6'R) Lutein (7)
(3 S,3'S,6'R)-3,3'-d ihydroxy-(3,s-carotene
H OH
HO' (3S,3'S,6'S) Lutein (8)
(3 S,3'S,6'S)-3,3'-dihydroxy-(3,e-carotene
Figure 1.7 These chemical structures show 8 lutein stereoisomers in nature
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2. Biological Functions
The role of carotenoids in photosynthesis has been extensively studied. In
photosynthetic systems, carotenoids are well known for their light-harvesting and photo-
protection roles in natural system.'5 One function of carotenoids is to prevent the
formation of singlet oxygen and hence protect the organism from this photo-oxidation
reaction. The other function of carotenoids is to act as accessory light-harvesting
pigments where they function by transferring their excitation energy to
bacteriochlorophyll through singlet energy transfer. It has been demonstrated that natural
all-trans (E) carotenoids are involved in this process. In plants and algae, carotenoids
serve as antioxidants that can be able to protect against photosensitized oxidation by
quenching the excitation energy of the chlorophyll triplet state and singlet oxygen.16
Recently, interest has focused on the role of antioxidant nutrients such as
vitamins A, C, and E and the carotenoids in the protection against oxidative processes in
biological systems.17 A comparison of dietary carotenoids has revealed that only select
groups of carotenoids are found in vivo. Among those most abundantly found in blood
are lutein and zeaxanthin. The other carotenoids include, lycopene (1), cc-carotene (2), 3-
carotene (3), and other common xanthophylls including, lactucaxanthin (4), p-
cryptoxanthin (5). Identified metabolites in human blood include oxo-lutein (6), epilutein
(7), ands,;-carotene-3,3'-dione (8), Figure 8. 18,19,20
7
2,6,10,14,19,23,27,31-octam ethyldotriaconta-
2,6,8,10,12,14,16,1 8,20,22,24,26,30-tridecaene
a-carotene (3)
HO OH
Lactucaxanthin (4)
s,s-carotene-3,3'-diol
/ 0
(3-cryptoxanthin (5)
Didehydro-4,5'-retro-P,P-carotene-3,3'-dione
0
HO
Oxo-lutein (6)
3-hydroxy-p,s-carotene-3'-one
HO OH
Epilutein (7)
(3R,3'S,6'R) Lutein o
O
e,-carotene-3,3'-dione (8)
Figure 1.8 The structures of several carotenoid commonly found in the biological systems
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Several studies have demonstrated that carotenoids act as antioxidants and may
have significant biological functions and activities in animals and humans. For example,
Bone and Landrum established that the macular pigment may play a protective role in the
eye. The main components in the human macular pigment are lutein and zeaxanthin.2'
The most important function of these carotenoids is to protect the central retina against
damaging photochemical reactions owing to the absorption of blue light. Because of the
short wavelength of blue light, it can induce the formation of reactive free radicals, triplet
excited states, superoxide, and singlet oxygen within the retina. ,23 The absorption of
blue light by the macular pigment can reduce the potential for light damage to the retina.
It is hypothesized that light-promoted damage to the retina is one of several
possible factors contributing to the development of age-related macular degeneration
(AMD), 4,25 The disease results in degeneration of the macula, leading to the loss of
central vision. As the increasing population ages, the prevalence of AMD is
increasing.26,27 Strategies for prevention or delay of the onset of AMD need to be studied.
Such strategies may support methods to reduce the prevalence of visual impairment and
blindness among the older people.
Bone and Landrum demonstrated that lutein and zeaxanthin were the two major
constituents of macular pigment in the retina.28 In 1988, Bone and Landrum investigated
the distribution of zeaxanthin and lutein throughout the human retina.2 1 They studied the
distribution of lutein and zeaxanthin from the center of the retina out to the periphery by
cutting the retina into concentric rings. They demonstrated that zeaxanthin is the
dominant component from the center of fovea out to 2.5 mm, while lutein is the principal
component in the peripheral retina. The ratio of lutein to zeaxanthin is shown in Table
9
1.1.29 They also investigated the relationship between age and the distribution of
zeaxanthin and lutein in human retina. They studied 87 donors between the ages of 0 and
95, no dependence on age was observed in the quantity of either pigment.2 For
approximately 90% of the samples, zeaxanthin was dominant in the central retinas. For
the remaining 10% of the samples from fetus to 2 years, lutein was the major component.
The dependence on age of the xanthophyll concentration is studied in first decade
samples, see Table 1.2.21 In 1991, Handelman et. al. measured the amounts of zeaxanthin
and lutein in the central retinas of monkeys.3' In 1993, Bone, Landrum investigated the
zeaxanthin and lutein stereoisomers in human plasma and the retina via the formation of
dibenzoate derivatives. The carotenoids in retinas reveal that a unique non-dietary
carotenoid, R,S-zeaxanthin, is present only in the macular pigment.30 This is meso-
zeaxanthin. They found only (3R,3'R)-zeaxanthin in the human blood. However, in the
human retina, they found two zeaxanthin stereoisomers, (3R,3'R)- and (3R,3'S)-
zeaxanthin. Because no (3R,3'S)-zeaxanthin exists in human blood and it is known that
humans are unable to synthesize the carotenoids, it was proposed that a chemical
conversion was occurring in human eyes. The ratio of (3R,3'S)-zeaxanthin to lutein is
greater in the macula relative to the periphery of the retina. 30,32 Recently, Johnson,
Neuringer et. al. investigated the source of meso-zeaxanthin in the monkey retina.
Monkeys were separated into 3 groups. The first group was fed a semipurified diet
containing all essential nutrients but no xanthophylls. The second group was
supplemented with pure lutein and the third group with pure zeaxanthin. At the
completion, carotenoids in serum, adipose tissue, and retina (central 4mm, 8mm annulus,
and the peripheral retina) were determined. Monkeys fed xanthophyll-free diets had no
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lutein or zeaxanthin in serum or tissues. After lutein or zeaxanthin supplementation,
serum and adipose tissue concentrations significantly increased in the supplemented
groups. Both lutein and 3R,3'S-zeaxanthin were present in retinas of monkeys
supplemented with lutein, with RSZ present only in the macula (central 4mm). RSZ or
meso-zeaxanthin, was not present in the diet. All-trans zeaxanthin, but no RSZ,
accumulated in retinas of monkeys supplemented with zeaxanthin. Their study
demonstrated that lutein is the precursor of RSZ, a major component of macular pigment.
The conversion of lutein to its isomer zeaxanthin in the eye is believed to take place in
the central macula.32
TABLE 1.1 The ratio of distribution of lutein and zeaxanthin in human retina varies with
distance from the center of the retina
The distribution from fovea (mm) Ratio of lutein/zeaxanthin
0-0.75 0.5
0.75-1.6 0.73
1.6-2.5 1.04
2.5-5.8 1.85
5.8-8.7 2.24
8.7-12.2 2.22
Based on previous work, it is known that the carotenoids that compose the
macular pigment in the human retina increase in amount during the first few years of life
and that the proportion of zeaxanthin also increases in the central retina during this time.
As the age increases, more lutein(L) must be converted to meso-zeaxanthin (RSZ).2 1
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TABLE 1.2 The amounts of carotenoids found in the macular in the first decade of life
Age (years) Lutein + zeaxanthin (ng) Lutein/zeaxanthin (mass ratio)
0 7 1.59
0.4 4.5 1.25
0.5 24.6 1.41
0.8 4.8 1.67
1.3 66.2 1.75
1.6 41.5 1.24
1.7 28.6 1.49
3 25.1 0.67
7 41 0.53
9 27.6 0.87
Oxidative metabolites also can be found in the retina. The amount of these
oxidative carotenoids is approximately 20% of the total carotenoid concentration. The
identity of these compounds has already been reported.2' These oxidized carotenoids are
reported to be oxo-lutein, epilutein, and s,s-carotene-3,3'-dione. If the main function of
carotenoids is to protect the biological system from the oxidative processes, then the
presence of oxidation by-products of these carotenoids in the body may provide an idea
of which processes may occur. The presence of oxo-lutein, meso-zeaxanthin, and
epilutein, which are not commonly found among the dietary carotenoids suggest that
some biochemical processes may result the metabolism of these compounds.
A possible mechanism for the formation of RSZ has been suggested involving
oxidation of lutein to produce oxo-lutein followed by synthetic reduction to produce RSZ.
Oxo-lutein, see Figure 1.9, contains an E-ring in which the carbonyl is conjugated with
the double bond. This compound may be reduced in vivo to produce RSZ. Another
possible intermediate may be the oxo-zeaxanthin, 3-hydroxy-P,3-carotene-3'-one. Oxo-
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zeaxanthin, see Figure 1.10, might also be expected to form from the oxidation of
zeaxanthin. This compound has not previously been described. In fact, there is reason to
believe, based on a general knowledge of carbonyl chemistry that the P,y-carbonyl
structure of oxo-zeaxanthin should readily tautomerize to the a,p-carbonyl structure oxo-
lutein, see Figures 1.11 and 1.12.
O
HO
Figure 1.9 The chemical structure of oxo-lutein
O
HO
Figure 1.10 The chemical structure of oxo-zeaxanthin
During the reduction of rhodoxanthin to produce racemic zeaxanthin, an
intermediate compound is produced that has at least moderate stability. It has been
suggested this compound is a diketone having the PP-ring structure where the double-
bond at the 3 and 3' carbons have a p,y-position relative to the carbonyl. Part of the work
described here has been to characterize this intermediate and to understand the stability of
carotenoids having this structure. This work will shed light on the possible reaction
pathway by which meso-zeaxanthin is formed.
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HO OH H
I HO
Zeaxanthin
Lutein [0]
[0]
Rhodoxanthin
HOO
HO \ O \
Oxo-lutein Q,4-dione
Figure 1.11 Possible reactions leading to oxidation products of lutein and zeaxanthin
H H
H
c-ring
H H
0
P-ring
Figure 1.12 The tautomeric relationship between p- and c-ring structures
This thesis considers two aspects of the problem of understanding the nature of
the macular pigment. The first part described in Chapter II will be the elucidation of the
structure of P,P-carotene-dione. The second part of this thesis, Chapter III, involves
measurement of the carotenoid distribution in the retinas of neonatal macaques. The
14
development and metabolism of the macular pigment in primate and human retinas still
remains an incompletely understood process and these studies will contribute new
information and serve as a basis for unraveling this physiological problem.
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CHAPTER II THE INTERMEDIATE PRODUCT FORMED BY REDUCTION
OF RHODOXANTHIN
1. Overview
The 3,3'-p3-carotene-diones were discussed in Chapter I. These compounds are
hypothesized to be metabolites of zeaxanthin in biological systems. Reduction of
rhodoxanthin results in the formation of the zeaxanthin stereoisomers, see Figure 2.1.
During this reduction xanthophyll compounds are formed whose structures have not been
unambiguously assigned. 3,3'-PP-carotene-dione is a suggested intermediate formed
during the 2 step reduction of rhodoxanthin to produce the zeaxanthin stereoisomers. To
isolate the intermediate of this reduction, two reactions are carried out. MnO 2 is employed
to oxidize R,R-zeaxanthin forming rhodoxanthin, which is subsequently reduced by
Zn/HOAc to form an intermediate compound, see Figure 2.1. This intermediate is
thought to be 3,3'-P,P-carotene-dione, compound 1, but the possibility that it is 3,3'-PP-
carotene-dione, compound 2 has not been ruled out.
0
4'
Compound 1, p4-carotene-3,3'-dione
Compound 2, c,e-caroten-3,3'-dione
Figure 2.1 Possible structure of intermediate formed during the reduction of rhodoxanthin
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Characterization of this intermediate product of rhodoxanthin has remained
incomplete. The reduction chemistry of rhodoxanthin remains an unresolved question, the
following is our work on this problem. Both analytical and spectroscopic methods, such
as, IR, UV/Vis, MS, NMR, and HPLC, are employed to identify the structure of this
intermediate.
2. Experimental Section
2.1 Oxidation of Zeaxanthin with MnO 2
Methods similar to Entschel et al.33 1959 were used to perform the zeaxanthin
oxidation reaction. All of the procedures were done in the dim light and all the containers
were wrapped with aluminum foil to avoid degradation and isomerization of carotenoids.
10 mg zeaxanthin were dissolved in 30 ml of dry distilled acetone to produce a
saturated solution. This solution was passed through a column of MnO 2 having the
dimension 35 x 5 mm at a flow rate of 1 minute. The reactant was characterized by a
color change from yellow/orange to cherry red. The solvent was removed by rotary
evaporator and the product further dried under a nitrogen stream. The product was
purified by preparative thin layer chromatography (Whatman PLK 5 Silica gel 150 A
Plate, 20x20 cm, 1000 pm). The sample was applied to the plate as an acetone solution.
After drying, the plate was eluted with a solvent mixture containing 75% hexane and
25% acetone. Rhodoxanthin product was obtained by scraping the rhodoxanthin band
from the plate dissolving in CH 2Cl 2 followed by filtration. The solvent was removed by
rotary evaporator and the pure rhodoxanthin was further dried under a nitrogen stream.
Samples were stored for further use at -80'C. UV/Vis of rhodoxanthin in EtOH, kmax=
490nm, see Figure 2.12. Mass spectrum of rhodoxanthin can be seen in Figure 2.13. IR
17
spectrum of rhodoxanthin can be seen in Figure 2.15. 1H NMR of rhodoxanthin can be
seen in Figure 2.14.
2.2 Reduction of Rhodoxanthin with Zn/HOAc
Rhodoxanthin was reduced by active granular zinc. Zinc was stirred with HCl-
ethyl ether solution for couple of minutes until zinc looked shiny. The HCl-ethyl ether
solution was prepared by gently shaking with concentrated HCl in a separatory funnel.
(Caution: Gas build-up can cause spraying of concentrated HCl if gas is not carefully
vented.) The ether solution was poured off and leaving the dry active zinc. The activated
zinc was washed with ethyl ether 3 times. Ethyl ether was evaporated and the dried active
zinc was used immediately for reduction reaction.
6 mg of purified rhodoxanthin was dissolved in 20 ml CH 2Cl 2 and 1 ml HOAc.
3.5 g of active zinc was added to the solution. The solution was stirred for 20-30 min
until it turned lemon yellow. At this time, the stirring bar was removed from the flask.
The reaction was quenched by addition of 1000 ml saturated NaHCO 3 solution. The
resulting mixture was extracted with CH 2C12 and cold deionized water. This extraction
procedure was repeated three times. The organic layer containing the carotenoid fraction
was dried over magnesium sulfate for 5 minutes followed by gravity filtration to remove
MgSO 4. The solvent was removed by rotary evaporation and further dried under a steam
of nitrogen in preparation for separation by preparatory reversed-phase HPLC. UV/Vis of
the intermediate product of rhodoxanthin in EtOH, kmax= 450 nm, see Figure 2.20. Mass
spectrum of the intermediate can be seen in Figure 2.21. IR spectrum of the intermediate
can be seen in Figure 2.23. 'H NMR of intermediate can be seen in Figure 2.22.
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2.3 Instrumental Analysis for Product Characterization
2.3.1 UV/Visible Spectroscopy (UV/Vis)
All carotenoids samples were dissolved in ethanol and pipetted into a UV cell (1 cm).
The UV/Visible spectra of reactant were obtained prior to reaction in order to compare
results. All spectra were obtained by scanning from 600-300 nm.34
2.3.2 Chromatography
2.3.2.1 Reversed-Phase HPLC
HPLC analysis was performed on a system composed of Waters 2690 Separations
Module and Model 996 photodiode array detector. The column used for separation
products was a Phenomenex Ultracarb 3pm ODS (250x4.6 mm) with a manual injection
loop volume of 50[l, and a flow rate of 1 ml/min. (System 1)
The separation was performed on a system composed of a LDC/Milton Roy
spectromonitor detector coupled to a LDC multiple solvent delivery system. The column
used for separation was a Phenomenex Ultracarb 3pm ODS (250x21.20mm) with an
injection loop volume of 500 pL, and a flow rate of 5 ml/min. (System 2)
Systeml analysis was performed monitoring at 452nm for zeaxanthin, 450nm for
the intermediate compound and 490nm for rhodoxanthin.34 System 2 analysis was used to
purify the reduced rhodoxanthin. 34 Both systems used an isocratic solvent composition of
85% acetonitrile, 15% methanol, with 1 ml triethlamine per liter of mobile phase added to
inhibit degradation of the carotenoids on the column and improve separation.35
2.3.2.2 Thin Layer Chromatography
TLC was done using Analtech sheets, Alumina GF 250pm. The solvent used to
develop the plates was composed of 75% hexanes and 25% acetone for rhodoxanthin and
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98% dichloromethane and 2% methanol for the reduced rhodoxanthin intermediate.29 The
samples to be analyzed were dissolved in the above solvent and applied with a spotter
made from a capillary tube by drawing in a flame.
2.3.2.3 Preparative Thin layer Chromatography
Preparative TLC was employed to purify rhodoxanthin. This was done using
Whatman PLK 5 Silica gel 150 A Plate (20 x 20 cm, 1000 pm). The solvent used to
develop the plates consisted of 75% hexanes, 25% acetone. Samples (rhodoxanthin and
its by-products) to be separated were dissolved in acetone in order to both minimize
sample volume and maximize evaporation rate of the solvent during plate preparation.
The TLC plates were spotted with a Pasteur pipette, the tip was drawn out in a flame to
produce a narrow capillary. After application, the solvent was allowed to evaporate while
keeping the plate in the dark for about 10 min. Plates were developed in a glass chamber
one time. The bright-red band was scraped from the plate, collected, and dissolved in
methylene chloride. The solution was filtered through filter paper and the solvent was
removed by rotary evaporation and the sample was further dried under a flow of nitrogen.
The resulting compound was stored in round bottom flask at -80 C.
2.3.3 Mass Spectrometry Analysis
Mass spectra were obtained on a Finnigan Navigator aQa Mass Spectrometer
equipped for APCI (atmospheric pressure chemical ionization). The positive-ion APCI
mode was selected. The column used for separation was a Phenomenex Ultracarb 3 1
ODS (150 x 4.6 mm) with a flow rate of 1 ml/min. Samples to be studied were dissolved
in ethanol. Samples were injected into the system by the autosampler, the mobile phase
was 85% acetonitrile and 15% methanol. NOTE: Et3N must not be used during MS
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detection because it will contaminate the instrument and suppress ionization. The
temperature in the chamber was set to 300'C. The voltage applied to the needle was set at
5 mV. Purified zeaxanthin, rhodoxanthin, and the reduced rhodoxanthin intermediate
were run separately. The mass spectra were recorded between 500-600 m/z. Background
(solvent blank) was subtracted in order to obtain a clean spectrum.
d) NMR Analysis
NMR spectra were obtained for zeaxanthin, rhodoxanthin and the reduction
product formed from rhodoxanthin, respectively. NMR data was obtained using a Bruker-
Electospin 400 MHz Ultrashield NMR spectrometer. Samples were greater than 90%
pure (HPLC) and were dried on a high vacuum pump for 30-45 min to remove all traces
of the solvent. About 0.6 ml of CDCl3 was used to dissolve the sample. Proton spectra
were obtained using the standard parameters available in the software package. The
number of scans used to obtain 'H-NMR was usually set to 32 or 1032, depending on
sample concentration.
e) Infrared Spectrometry (IR)
The IR system used was a MIDAC M2000 Series FTIR spectrometer. Samples
were dissolved in dichloromethane and transferred carefully by a Pasteur pipette to the
surface of NaCl plate to obtain an even coverage under nitrogen. The NaCl plate without
sample was used as the blank.
3. Results and Discussion
In order to analyze the zeaxanthin stereoisomers in the tissues, see chapter III, we
need to prepare the three zeaxanthin stereoisomers. The procedure is shown in Figure 2.2.
This procedure involves formation and isolation of a intermediate product, compound 1,
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that has been previously described as 3,3'-,-carotene dione. The evidence for this
assigned structure is solely the formation of the zeaxanthin isomers which result from a
subsequent NaBH 4 reduction of this compound, see Figure 2.2. We describe the
purification and characterization of compound 1 below.
3.1 Zeaxanthin
Zeaxanthin will be the first compound to be discussed in this section. It is the
starting material for our studies and because of the extremely close similarity of these
compounds it is imperative that we characterize all products by careful comparison to this
starting material. It is discussed in order to establish the basis by which the other
compounds have been examined. In this manner it will be easier for the reader to
understand the concepts and criteria used to assign the identity of the compounds studied.
3.1.1 Results
3.1.1.1 HPLC analysis
Because of the similar structures of the lutein and zeaxanthin, their
chromatographic retention times are very close. The HPLC chromatogram of a lutein and
zeaxanthin mixture is shown in Figure 2.3. The retention time of lutein is 11.75 min
while the retention time of zeaxanthin is 12.90 min.
3.1.1.2 UV/Vis analysis
UV/Vis spectrum of zeaxanthin in EtOH is shown in Figure 2.4. The kmax is
452nm. The two bands at either side of the main absorption band are observed at 424 and
478 nm, respectively. The ratio of the vibrational bands (III/II) was calculated to be 28%.
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3.1.1.3. MS analysis
MS analysis of carotenoids was done using APCI+. This is a soft ionization
method and generally gives quasi-molecular ions. In the case of zeaxanthin, mass spectra
produce a higher intensity 569 parent ion and this is the principle ion of the mass
spectrum and the 551 peak.
OH
HO
Zeaxanthin
(3R,3'R)-3,(3-carotene-3 3'-diol
MnO 2
OO
Rhodoxanthin
3,3'-Diketo-retro-dehydro-p-carotene
HOAC
Zn
Intermediate reduction product
(Compound I or compound 2)
NaBH 4
OH
HO
Zeaxanthin stereoisomers
(3R,3'R)-p,p-Carotene-3',3'-diol (25%)
(3R,3'S)-3,p-Carotene-3',3'-diol (50%)
(3S,3'S)-3,3-Carotene-3',3'-diol (25%)
Figure 2.2 Procedure for the synthesis of zeaxanthin stereoisomers
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Zeaxanthin
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1.20
1.00-
Lutein
0.80-
0.0
0.40
0.20j
2.00 4.00 6.00 8.00 . 10.00 12.00 14.00
Minutes
Figure 2.3 Lutein and zeaxanthin detected using HPLC System 1. Lutein retention
time = 11.75 min, zeaxanthin retention time= 12.90 min.
0.20 2 452 nm
II ''4
0.18 I III
0.16 X1 =424 nm
0.14 t
3 478nm
0.12-
S0.10
0.06
0.04
0.02-
0.00
300.00 350.00 400.00 450.00 mO .00 550.00
nm
Figure 2.4 UV/Visible spectrum of zeaxanthin in EtOH. X max= 452nm.
III/II= 28%
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Figure 2.5 The APCI + mass spectrum of zeaxanthin showing the principle ion
[M+H]=569 m/z, and the fragment produced by loss of H20 [MH-18]=551 m/z.
3.1.1.4 NMR analysis
Proton NMR spectra of carotenoids are extremely complicated, see Figure 2.6.
These compounds have over 50 hydrogens atoms. This large number of protons together
with the complex splitting patterns makes it very hard to unambiguously assign identities.
Since the focus of this research is the oxidation of zeaxanthin hydroxyl group, the most
important assignments will be unique the protons on the ionone rings. These are readily
assigned. The structure of the f-ionone rings present in zeaxanthin is shown in Figure 2.7.
The hydrogen atoms are numbered consistent with the common numbering system. Table
2.1 lists the observed resonance and literature values of peaks for the critical hydrogens.
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Figure 2.6 The 'H-NMR of zeaxanthin obtained in CDC13
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Figure 2.7 The chemical structure of ionone ring on zeaxanthin
TABLE 2.1 Experimental 'H-NMR data and literature values
for zeaxanthin
6(ppm)* Experimental chemical Literatural chemical shift
shift (ppm) (ppm)
a H-C(2) 1.48 1.48
b H-C(2') 1.74 1.77
c H-C(3') 4 4.01
d H-C(4) 2.05 2.04
e H-C(4') 2.39 2.39
* a, b, c, d, e refer to the positions of hydrogens on the spectrum, see Figure 2.6
3.1.2 Discussion
The origin of the UV/Visible spectrum in carotenoids is the fully allowed 71-+7*
transition of the conjugated 7t system. The longer the conjugated double-bond chain, the
less the energy needed for the transition, and hence, the longer the wavelength at the
maximum absorption. Because of characteristic vibrational modes in the carotenoid
molecules, three bands are observed on the spectrum. The different intensity of each band
provides the valuable information. III/II ratio is a useful one. This ratio is the height of
the band of peak III absorbing at the longest wavelength, divided by peak II, the middle
absorption band; (this is usually the principle kmax). For carotenoids possessing 2p rings,
the III/II ratio is about 30%, for p,y-carotenes, it is about 45%, and carotenoids with g,c;
y,y; or a,a rings give 111/II ratios of about 100%.36
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The base peak is given by a fragment at [M+H]+ at 569 m/z. This corresponds to
the molecular weight of the molecule, 568 g/mol. Mass spectrometry gave a [M+H-18]+
at 551 m/z. This fragment is due to the loss of water, after the protonation of one of the
alcohol groups.
Because zeaxanthin has a symmetric structure, the assignment of the peaks on
NMR spectra is also symmetric. However, it is very difficult to assign the location of
each proton in the carotenoid on 'H-NMR spectra. A broad peak around 4.00 ppm was
assigned to the axial proton at C(3,3'). Peaks around 1 to 2 ppm were assigned to the
protons on saturated methyl carbons [C(2,2'), C(4,4'), C(16,16'), C(17,17'), C(18,18'),
C(20,20')]. Those around 6 ppm were contributed by the olefinic protons on the double
carbon bonds [C(7,7'), C(8,8'), C(10,10'), C(11.11'), C(12,12'), C(14,14'), C(15,15')].
The peak at 7.28 ppm was caused by the residual protons in the solvent (CDCl3 ) and this
value is identical to the data in the literature (6=7.26 ppm).38 Other data are also
consistent with those in the literature.37
3.2 Oxidation of zeaxanthin with manganese (IV) oxide
The mechanism of retro rearrangement of double bonds for the biosynthesis of
4',5'-didehydro-4,5'-retro-p,p-carotene-3,3'-diol is still unknown. However,
Williams et. al.39 proposed a possible mechanism for it and Britton40 also suggested a
similar oxidation process in the biosynthesis of rhodoxanthin. So the possible process
which might be involved in the oxidation reaction of zeaxanthin was proposed as shown
in Figure 2.8.
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Zeaxanthin
H
O
Rhodoxanthin
Figure 2.8 Partial synthesis of rhodoxanthin involves the loss of 6 electrons
Reaction of zeaxanthin with MnO2 proved to be an efficient way of synthesizing
rhodoxanthin and it can produce several different products. A single compound is present
in high yield, and the other compounds were observed in very low yields (5% or less).
The main compound, rhodoxanthin, was collected using preparative TLC, as described in
Figure 2.10. Once the rhodoxanthin fraction was separated, it was stored under nitrogen
in the dark at -80'C for further analysis and reaction.
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3.2.1 Results
3.2.1.1. HPLC analysis
The chromatogram in Figure 2.9 shows the HPLC analysis (system I) of
rhodoxanthin. The rhodoxanthin product was observed at a retention time of 9.75 min
and 10.50 min, respectively.
0.12-
0.101 ;
Cis-rhodoxanthin and
0.08- trans-rhodoxanthin
= 0.06
Zeaxanthin
0.04 Oxo-lutein
0.02
2.00 4.00 6.00 8.00 10.00 12.00 14.00
Minutes
Figure 2.9 The product mixture resulting from reaction of zeaxanthin and MnO 2 detected
with HPLC system I
3.2.1.2. Separation and Purification
Separation and purification of this rhodoxanthin was done by preparative TLC.
This was possible due to the large yield obtained from the reaction, which enabled the use
of this chromatographic technique as opposed to HPLC. Figure 2.8 shows a developed
plate. The purified rhodoxanthin is shown in Figure 2.10.
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Zeaxanthin
Rhodoxanthin
Oxo-lutein
Other oxidation products
Figure 2.10 TLC showing separation between rhodoxanthin and the rest of the reaction
by-products
HPLC analysis (system I) of rhodoxanthin gave a retention time of 6.2 min. The
compound analyzed by HPLC was obtained from collection on preparative TLC. This
HPLC system proved to give a mixture of isomers of rhodoxanthin and enable the
separation of relatively large amounts of compound.
0.a
0.07 Cis and trans-rhodoxanthin
0.06-
0.05
2 0.04
0.03-
0.02 Oxo-lutein
0.01 -
0........-..---- ------ ,-
2.00 4.00 8.00 8.00 10.00 12.00
Figure 2.11 Purified rhodoxanthin from TLC
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3.2.1.3. UV/Visible analysis
UV/Visible analysis of rhodoxanthin shows max of 490nm. It can be seen in
Figure 2.12.
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0.09-
0.068
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0.00-
0.0 .
0.04.a
0.03
0.02
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0.00 _________________________
300.00 350.00 400.00 450.00 500.00 550.00
nm
Figure 2.12 UV/Visible spectrum of Rhodoxanthin in EtOH, kma,= 490n..
3.2.1.4 MS analysis
Mass spectrometry shows the presence a molecular ion [M+H]+=563 m/z, which
is the base peak. This mass is consistent with the molecular weight 562 g/mol of
rhodoxanthin. It can be seen in Figure 2.13.
3.2.1.5 NMR analysis
The proton NMR as in the case of rhodoxanthin is hard to assign due to the large
number of hydrogens in the structure and their coupling. The NMR spectrum can be seen
in Figure 2.14. In the following table, a number of the peaks are tentatively assigned.
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Although these splitting patterns are extremely complex, these assignments allow us to
unambiguously assign the structure of the ring.
5633
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Figure 2.13 The APCI + mass spectrum of rhodoxanthin. [M+H]+=563 m/z.
Table 2.2. Experimental 400 Hz 'H-NMR data and literature data of
rhodoxanthin
Proton Experimental Literature at 400 MHz
6(ppm)* schemical integration all-trans 6-cis 6,6'-di-cis
a H-C(2) 2.396 2 2.395 2.340 2.341
b H-C(2') 2.396 2 ~2.394
c H-C(4) 5.939 1 ~35.937
d H-C(4') 5.939 1 ~5.937
* a, b, c, d refer to the position of hydrogens on the spectrum, see Figure 2.14
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3.2.1.6 IR analysis
As can be observed in Figure 2.15, a sharp and strong band is present at
1660 cm'
iH
Vc=o = 1660cm-
Figure 2.15 IR spectrum of rhodoxanthin
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3.2.2 Discussion
The chromatogram of purified rhodoxanthin can be seen in Figure 2.11. In
addition of trace of cleavage products and oxo-lutein residue, there are 2 basic peaks.
Both of them are rhodoxanthin because rhodoxanthin has 3 isomers in literature. 364041 It
can be seen in Figure 2.16.
OH
H O
Zeaxanathin (all-trans)
MnO 2
4'
5' 3'
6' 2
3 4 5 Rhodoanthn (6,6'E
O Rhodoxanthin (6E,6'E)
0
O Rhodoxanthin (6Z,6'Z)
O
00
Rhodoxanthin (6E,6'Z)
Figure 2.16 Oxidation reaction of zeaxanthin and the structures of all-trans
rhodoxanthin and its 6,6'-di-cis, 6-cis isomers.
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From the UV/Vis spectrum, a max for rhodoxanthin is found to be 490 nm. This
value is longer than the 452 nm k max of zeaxanthin. This bathochromic shift is consistent
with increasing conjugation in the system. Another important feature can also be seen in
the spectrum. Rhodoxanthin has a broad spectrum without the fine structure of
zeaxanthin, which has a characteristic three-band carotenoid spectrum. The difference
between the two spectra is due to the presence of the two carbonyl groups conjugated
with the polyene chain. The presence of conjugated carbonyl groups causes a large
bathochromic shift of the spectrum. The overall bathochromic shift is about 40 nm
relative to zeaxanthin and is consistent with the increase in the number of double bonds
in the polyene chain.
Since there are three isomers of rhodoxanthin, it is very difficult to assign the
location of each proton in the 'H-NMR spectrum. Among the three structures of
rhodoxanthin, see Figure 2.16, the all-trans and the 6,6'-di-cis rhodoxanthin are
symmetric, therefore, they have half as many peaks in the 'H-NMR spectrum that of the
asymmetric 6-cis rhodoxanthin.42
The peaks around 1.0 to 2.5 ppm were assigned to the protons on the saturated
methyl carbons [C(2,2'), C(16,16'), C(17,17'), C(18,18'), C(19,19'), C(20,20')]. Those
around 6 ppm were attributed to the olefinic protons on the double carbon bonds [C(4,4'),
C(7,7'), C(8,8'), C(10,10'), C(11,11'), C(12,12'), C(14,14'), C(15,15')]. The peak at 7.28
ppm is due to the solvent (CDCl 3).38 A broad peak around 1.7 ppm might be caused by
residual H20 in the solvent. There are 2 hydrogens attached on the C2 and a hydrogen
attached to the C4 on the end-rings. The ratio of their integrations is identified to 2:1 (a:c).
The data are consistent with those reported in the literature.37
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While infrared spectroscopy does not provide information about the structure of a
molecule, it was helpful in confirming the presence of the carbonyl groups. The
frequency of an isolated carbonyl in the IR spectrum is typically observed at about 1720
cm~1. The 1660 cm4 1 CO frequency in our samples is consistent with the assignment as an
a,3-unsaturated carbonyl.
3.3 The intermediate carotene dione
This reduction product of rhodoxanthin, compound 1, is unstable, and only small
amounts of this compound could be isolated because they rapidly oxidize back to
rhodoxanthin. Thus, it proved very challenging to obtain the spectra needed to adequately
characterize this species.
Figure 2.17 are possible structures of the intermediate product formed by the
reduction of rhodoxanthin. Although this intermediate has been previously described as
compound 1, see Figure 2.17, its structure has remained unproven. Compound 2 is
another candidate for the structure of this product. The reason is that carbonyl compounds
with an p3,y double bond often readily tautomerize to produce the more stable a,p-
unsaturated carbonyl system. It would not be surprising if compound 1, when formed,
would readily transform into compound 2. The end-groups of compound 2 are the E-
ionone rings in which the carbonyl at C3 is conjugated to the ring double bond. Oxo-
lutein, a related keto-cartenoid, has an identical c-ionone ring containing a conjugated
carbonyl at C3. It has been previously studied in our lab. The NMR spectra of oxo-lutein
can be seen in Figure 2.24. 'H-NMR spectrum of the &-ring is distinctly different from
that of the p-ring system.
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Figure 2.17 The possible candidates for the reduction product formed by the reaction of
rhodoxanthin with Zn/HOAc
3.3.1 Results
3.3.1.1 HPLC analysis
Compound 1 (produced by Zn/HOAc reduction of rhodoxanthin) was collected
and purified by HPLC (System 2). The retention time was determined by HPLC (system
1). The elution time of compound 1 on this system was determined to be 8.30 minutes.
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The reason being the smaller column used in this experiment gives more consistent and
reproducible results than system 1. The chromatogram can be seen in Figure 2.18 and
Figure 2.19.
The reversed-phase chromatogram of the intermediate
product of rhodoxanthin reduction and other by-products
1.10E-01
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1.00E-02
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Minutes
Figure 2.18 HPLC of product mixture formed by reduction of rhodoxanthin with
Zn/HOAc
The reversed-phase chromatogram of purified product from the
reduction of rhodoxanthin
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Figure 2.19 Purified compound 1 from reduction of rhodoxanthin with
Zn/HOAc (system II)
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3.3.1.2 UV/Vis analysis
UV/Visible spectrum of compound 1 has three absorption bands. Band II, k max
in EtOH was at 450 nm.
ax= 450 nm
kmax= 478 nm
0.07 /\
II / I0.06 \ 1
ax= 424 nm r
0 .0 5
0.04
0.0 3 /r
0.02
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300.00 350.00 400.00 450.00 500.00 550.00
nm
Figure 2.20 UV/Visible spectrum of compound 1. kmax= 450nm. III/II= 50%
3.3.1.3 MS analysis
MS analysis of carotenoids was done using APCI positive ion method. The Figure
2.21 shows base peak at 565 m/z.
3.3.1.4 NMR analysis
NMR, see Figure 2.22, for compound 1 has a large number of peaks. In the
following table, some of the data from the unknown compound (the intermediate product
formed by the reduction of rhodoxanthin) are assigned proton NMR spectra. These
assignments enable us to identify the type of the ionone ring.
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Figure 2.21 The APCI+ Mass Spectrum of the reduction of rhodoxanthin
Table 2.3 Experimental 'H-NMR data of intermediate product formed by
reduction of rhodoxanthin
Proton 6ppm (f- Chemical Shift (p- Integration
ring) ring)
a. H-C(1) 1.084 3
b. H-C(2) 2.415 1
c. H-C(4) 2.895 1
d. H-C(6) N/A N/A
a, b, c, d refer to the position of hydrogens on the spectrum
(see Figure 2.22)
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Figure 2.22 'H-NMR of compound 1 obtained in CDC13, 400MHz
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3.3.1.5 IR analysis
Infrared spectroscopy was helpful in confirming the presence of the carbonyl
functional groups in the compound. As it can be observed in Figure 2.23, the presence of
a carbonyl is confirmed by a sharp, strong band at 1720 cm'.
Vc=o = 1720cm'
Figure 2.23 IR of the compound 1
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As mentioned previously, oxo-lutein, which processes an c-ring, has been
extensively studied in our lab. We can compare the spectrum of E-ring of oxo-lutein with
the spectrum of compound 1. The spectrum of oxo-lutein is shown in Figure 2.24. The
chemical shifts and integrations are listed in following table.
Table 2.4 Experimental 'H-NMR data and literature data of oxo-lutein
Exprimental Literature 37 at 400 MHzProton 6(ppm) Exrmna(pp chemical shift integration chemical shift integration
a H-C(2) 1.94 2 2.10/2.38 2
b H-C(4) 5.84 1 5.91 1
c H-C(6) 2.62 1 2.61 1
a, b, and c refer to the positions of hydrogens on the spectrum, see Figure 2.24
3.3.2 Discussion
UV/Vis shows the wavelength maximum (band II) of the intermediate product
(compound 1) formed from the reduction of rhodoxanthin is observed at 450 nm. Bands I
and III, at either side of the main absorption band are observed at 424 nm and 478 nm,
respectively. ? max is nearly that identical to be observed for zeaxanthin. A useful feature
of carotenoid spectra is the III/II ratio. The ratio of the vibrational bands (III/II) for
compound 1 is 50%. This value proves that the end-groups in the molecule are not 2E
rings. Another important feature of the spectrum should be emphasized, like zeaxanthin,
compound 1 has 3 bands and therefore the carbonyls are not conjugated with the polyene
chain. The k max of compound 1 was observed at 450 nm as opposed to the single broad
band observed for rhodoxanthin of 490 nm. This hypsochromic shift is consistent with a
loss in conjugation in the system. The overall hypsochromic shift of about 40 nm
compared to rhodoxanthin indicates that three bonds have been lost in the conjugated
system.
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Figure 2.24 'H-NMR of oxo-lutein (c-ring) obtained in CDC13, 400MHz
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The mass spectrum shows a quasimolecular ion at [M+H]+=565m/z. This peak
corresponds to the molecular weight of the final product plus the addition of a proton.
The mass is consistent with the proposed structure, Figure 2.17
NMR peaks between 1.0 to 2.5 ppm were assigned to the protons on saturated
methyl carbons [C(2,2'), C(4,4'), C(16,16'), C(17,17'), C(18,18'), C(19,19'), C(20,20')].
Those around 6 ppm are attributed to the olefinic protons on the double carbon bonds
[C(7,7'), C(8,8'), C(10,10'), C(11,11'), C(12,12'), C(14,14'), C(15,15')]. There is no
literature NMR data for this compound. The peak at 7.28 ppm was caused by the residual
proton in the solvent (CDCl 3) and this value is identical to the data in the literature
(6=7.26 ppm).38 A broad peak around 1.8 ppm was caused by residual H20 in the solvent
or saturated fatty residue in the sample.
Because identification of a carotenoid is primarily dependent on assignment of the
structure of the end-group rings the assignment of the NMR peaks of the ionone ring H-
atoms is very important. The intermediate formed by the reduction of rhodoxanthin is
very unstable, so the limited amount of sample can be obtained to elucidate the structure.
Since only 'H-NMR spectrum can be obtained, it is challenging to fully elucidate the
structure. The only unambiguous way to distinguish between the different end-groups is
to compare the difference between proton resonances in the end-rings. As seen in Figure
2.25, the difference between P-ring and c-ring is the position of carbon-carbon bond.
From the structure, it is clear that H(d) is present in the c-ring, while H(d) is absent in the pf-
ring. There is only one H(C) in the c-ring, while two H(c)s are present in the P-ring.
Therefore, H(d) peak should be absent on the spectrum of compound 2. The integration of
H(a):H(c) or H(b):H(c) in the P-ring is 3:1, while H(a):H(c) or H(b):H(c) is 6:1 in the c-ring. H(d)
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is a critical hydrogen in the structure. The spectrum of oxo-lutein (Figure 2.24) shows a
singlet peak -2.6 ppm, while no peaks near 2.6 ppm are present in the spectrum of the
intermediate formed from the reduction of rhodoxanthin. This is consistent with a p-ring
assigenment. Another critical hydrogen in the structure is H(c) Because the H(c) is attached
to the sp 2 carbon center in the E-ring, the H(c) resonance is downfield at ~5.9 ppm, while
in the P-ring, since H(c) is attached to the sp 3 carbon center, the H(c) resonance is upfield
at -2.8 ppm. The resonance of ~5.9 ppm should be absent on the n-ring spectrum. Even if
some peaks are downfield at -5.9 ppm on the 3-ring spectrum, they might be from
olefinic protons on the double carbon bonds. A minor peak at 5.9 ppm is present in the
spectrum of compound 1. However, the integration of the peak at 5.9 ppm, 2.4 ppm [H(c)],
and 1.1 ppm [H(a)] are 0.02, 0.31, and 1, respectively. Table 2.5 presents a comparison of
resonances for the intermediate obtained by reduction of rhodoxanthin and those of the E-
ring in oxo-lutein. The ratio of integrations between 5.9 ppm and 2.4 ppm [H(c)] is 1:15,
and 5.9 ppm and 1.1 ppm [H(a)] is 1:50. Thus, on the P-ring spectrum, we conclude that
the peak of 5.9 ppm is from the impurity in the reduction of rhodoxanthin.
H CH(a)3 CH(a)3  H(b) CH(a) 3 CH(a)3(b(b H(d)
H(b) p H(b) E
H(c) H(c)
H(C)
Figure 2.25 The chemical structure of p-ring and E-ring
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TABLE 2.5 Chemical shifts, integration, and assignments of different hydrogens in the
intermediate product formed by reduction of rhodoxanthin
Proton 6ppm Chemical Shift Integration
P t F p p m
a. H-C(1) 1.084 1.1 3 6
b. H-C(2) 2.415 1.936 1 2
c. H-C(4) 2.895 5.84 1 1
d. H-C(6) N/A 2.62 N/A 1
4. Conclusion
Compound 1 was prepared by synthesis from all-trans zeaxanthin by in vitro
oxidation with MnO 2, followed reduction with Zn/HOAc in CH 2Cl 2. Preparative TLC
and preparative reversed-phase HPLC were used to purify rhodoxanthin and the
compound 1, respectively. Compound 1 was collected for further identification. HPLC
retention time, IR, and MS information demonstrate compound 1 is a diketone having the
formula C40H52 0 2. IR spectrum of compound 1 shows a strong absorption at 1720 cm-1
consistent with presence of the isolated carbonyl. APCI+ MS spectrometry shows a base
peak at 565 m/z and demonstrates that the molecular weight of compound 1 is 564.
UV/Visible spectrum of the compound 1 shows X max=450nm, and III/II=50%. Study of
the 'H-NMR was carried out in order to characterize the ionone rings. By comparison of
chemical shifts and integrations of ionone ring protons in compound 1 to those
compounds such as, oxo-lutein (Figure 2.26), the end-groups of compound 1 were
demonstrated to have NMR spectra consistent with the P-ring but not an c-ring. We
conclude that the structure of compound 1 is elucidated to be pP-carotene-3,3'- dione.
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0Figure 2.26 The elucidated structure of compound 1
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CHAPTER III MEASUREMENT OF THE CAROTENOIDS STEREOISOMERS
IN THE NON-HUMAN
PRIMATE RETINA, NEONATAL RETINA AS A FUNCTION OF AGE
1. Overview:
Zeaxanthin and lutein are the two main components of macular pigment in the
inner macula.2 1 Lutein and zeaxanthin are yellow pigments and are widespread in nature.
Zeaxanthin, P,P-carotene-3,3'-diol, see Figure 3.1, is a common component in human
serum. Although it is not the most abundant carotenoid in serum, it is a main component
of macular pigment in the inner macula where the concentration of zeaxanthin is about
twice that of lutein.2 Lutein is also a common micronutrient, and it is also one of the
most abundant carotenoids found in the human body. The structure of lutein, P,s-
carotene-3,3'-diol, is shown in Figure 3.2. Both lutein and zeaxanthin act as antioxidants
in biological systems.
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Figure 3.1 The chemical structure of zeaxanthin, A, (PP-carotene-3,3'-diol) and
lutein, B, (f,E-carotene-3,3'-diol) are shown above.
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The macula is the anatomical region of the retina that is responsible for central
vision. The macular pigment has a protective function for shielding the central retina
from excess blut-light. 26 The neutral retina is composed of several functionally and
structurally distinct layers overlaying and supporting the cone and rod photoreceptors. It
is in the inner layers of the retina, the so-called Henle fibers, consisting of the neural
axons in which the largest amount of macular pigment is found.26 Macular lutein is
believed to function as a blue light filter by absorbing a significant portion of blue light
that reaches the retina.23 In the average person the macular carotenoids can reduce the
blue light intensity reaching photoreceptors by about 40 percent.2 Blue light can cause
the formation of singlet oxygen, triplet excited state species, and free radicals. Lutein and
zeaxanthin may act as active quenchers of singlet oxygen, and excited state triplets. They
can react with and deactivate radical species preventing chain propagation. 45 These
actions all appear to be functions of carotenoids of the macular pigment.
Age-related macular degeneration (AMD) is one of the eye diseases which
disrupt the normal functioning of the macula. It occurs in about 20% of people over the
age of 65.22,2 As the population ages, there is an accompanying need to identify
strategies that will prevent or delay the onset of AMD. Such strategies must reduce the
prevalence of visual impairment and blindness among the elderly. Increasing macular
levels of lutein and zeaxanthin may play an important part of these strategies.24
Zeaxanthin (Z, including RRZ, RSZ, and SSZ) exists naturally in 3 distinct
stereoisomeric forms, R,R-zeaxanthin (RRZ), S,S-zeaxanthin (SSZ), and R,S-zeaxanthin
(RSZ), see Figure 3.2. RRZ is the most common form of zeaxanthin and is the only
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stereoisomer produced in higher plants. The other two isomers are only occasionally
found and generally are the result of metabolism in animals. 46
OH
HOO
(3R,3'R)-p,p -carotene-3,3'-diol
HO
(3R,3'S)-P. -carotene-3,3'-diol
HO'
(3S,3'S)-P,p -carotene-3,3'-diol
Figure 3.2 The three stereoisomers of zeaxanthin 3R,3'R-3,-carotene-3,3'-diol (3R,3'R-
zeaxanthin), 3S,3'S-3,p-carotene-3,3'-diol (3S,3'S-zeaxanthin), and 3R,3'S-pP-carotene-
3,3'-diol (3R,3'S-zeaxanthin).
Based on previous work, the distribution of zeaxanthin and lutein throughout the
human retina and the change in lutein and zeaxanthin in human retina with age has been
investigated by Bone and Landrum.2 1 Also, Johnson and co-workers have demonstrated
that lutein is the precursor of RSZ, a major component of macular pigment.32
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Our study, prompted by earlier results, is an investigation of the carotenoid
distribution in any single retina from 32 non-human primates in order to determine if
there is a relationship between the amounts of the carotenoids found in the retina and age
in the earliest stages of development.
2. Experimental Section
2.1 Reagents and materials
HPLC grade methanol, acetonitrile, hexane, isopropanol, and ethanol were
purchased from Fisher. Primate retinas were obtained from the Oregon National Primate
Research Center in accordance with institutional IACUC requirements.
2.2 Apparatus
Reversed-phase HPLC system 1, is a Waters 2690 separation module coupled
with a Waters 486 tunable absorbance UV/Visible detector and Water 996 photodiode
array detector. Reversed-phase HPLC system 2, is an LDC Analytical ConstaMeric 3200
solvent delivery system equipped with a 500 pl injection loop and coupled with a Thermo
Finnigan Spectra system UV1000.
2.3 Procedures
All retina samples were analyzed on a reversed-phase column (Phenomenex,
Ultracarb 3 pm ODS, 150 mm X 4.6 mm) HPLC and a normal-phase, chiral column
(Chiralpak AD-H, Derivatized amylose, 250 mm X 4.6 mm) HPLC. Zeaxanthin and lutein
in the retinas were separated by reversed-phase HPLC, and then, the purified zeaxanthin
was analyzed on the normal-phase chiral column. An internal standard, mono-propyl
lutein (MPrL), was used to quantify carotenoids. The concentrations of zeaxanthin and
lutein were determined by comparison to the peak area of the internal standard.
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2.4 Retina extraction
The retinas of primate eyes were cut into three sections, an inner ring (0-2 mm), a
medial ring (2-4 mm), and an outer ring (4-8 mm), see Figure 3.3. For analysis a section
of retina was transferred into a glass tissue homogenizer containing 10 pl mono-propyl
lutein (see internal standard section) and 2 ml of acetone. The concentration of the
internal standard was 24 ng per 10 pl. The homogenized mixture was filtered through a
0.22 pm nylon-mesh syringe filter and evaporated under a stream of pure nitrogen in a
glass vial. The yellow carotenoids were dissolved in acetone and a whitish residue
deposited on the wall of the vial. This vial was rinsed with cool acetone. The yellow
solution was evaporated under nitrogen. All of these procedures were performed carefully
under conditions of a dim light. The extracted carotenoid sample was dissolved in 8 pl of
ethanol for HPLC analysis, or the dried extracted carotenoid sample was stored in the
dark -80 C prior to HPLC analysis. To minimize experimental errors, all injections are
handled by manual injection.
2 mm section
4 mm section
famK 8 mm section
Figure 3.3 A view of a retina showing the sectioning. The retina was sectioned using
punches that were 2, 4, and 8 mm in diameter
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2.5 Preparation of the Internal Standard, 3-hydroxy-3'-propoxy-3,s-carotene, MPrL
The internal standard was chosen because of its chemical similarity to that of the
analyte. It was shown that lutein and zeaxanthin and the internal standard have same
percent recovery in the process of extraction and behave similarly on the HPLC column
differing only in retention time. Both assumptions have been proven in a previous study
in our group.36 Mono-propyl lutein was chosen as an internal standard for quantitative
analysis of extracted carotenoids from retina in this experiment.35 The structure of MPrL
is shown in Figure 3.4.
H O
H_
H O
Figure 3.4 The chemical structure of monopropyl lutein, 3-hydroxy-3'-propoxy-B,E-
carotene.
Monopropyl lutein was synthesized as follows:
An acidified propanol solution was prepared by adding 10 ml concentrated HCl
to 90 ml 1-propanol. About 3 mg of dry lutein was dissolved in 10 ml 1-propanol. The
acidified alcohol solution containing the lutein was stirred at 22 C for at least 30 min to
ensure that the reaction reached completion. About 50 ml of saturated NaHCO3 solution
was transferred to the mixture to quench the reaction. The carotenoids were extracted
with 3 equal portions of CH 2Cl 2. The CH 2Cl 2 aliquots were combined and evaporated by
a rotary evaporator. The resulting carotenoid reaction mixture containing MPrL was
dissolved in acetone and purified by a reversed-phase HPLC system 2 (LDC/Milton Roy
solvent delivery system) which is coupled to a UV-Visible detector set at 447 nm. A
manual injector with a 500 pl injection loop was installed in this HPLC system. The
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column used was a Phenomenex Ultracarb ODS 3 l (250 x 21.20 mm). The flow rate
was 5ml/min. The mobile phase used was 85% acetontrile, 15% methanol, with 0.1%
(V:V) of triethylamine added. The MPrL peak was collected at a retention time of 40 min
and concentrated by rotary evaporator and dried under a stream of nitrogen gas. The
purified MPrL was redissolved in ethanol. The concentration of MPrL was determined
from the absorption of the resulting solution at a wavelength of 447 nm. The absorption
coefficient of MPrL is identical to that of lutein = 1.5x10- M-1 cm'.
2.6 Preparation of zeaxanthin racemic mixtures
In order to measure the zeaxanthin stereoisomer composition in the tissue, we
prepared standards of all three zeaxanthin stereoisomers. The two steps of this procedure
are described in Chapter II. The last step was carried-out as follows: Pp-Carotene-3,3'-
dione was redissolved in methylene chloride. Treatment of the methylene chloride
solution with sodium borohydride resulted in no color changes. The resulting product
contains a statistical mixture of the three zeaxanthin stereoisomers which were
characterized by UV spectrum and HPLC retention time. The retention time of the
racemic zeaxanthin stereoisomers is 6.3 min on reserved-phase HPLC and is consistent
with an authentic zeaxanthin standard. The racemic mixture of three zeaxanthin
stereoisomers was resolved by chiral normal-phase HPLC, as illustrated in Figure 3.5. In
Figure 3.5 the fourth peak is lutein. From Figure 3.5, it is seen that the second eluting
peak is as twice size as the first and third peaks, so, based on the statistical distribution,
the second peak of zeaxanthin isomers is identified as (3R,3'S)-zeaxanthin (RSZ). The
R,R-zeaxanthin stereoisomer was identified as the third peak in the chromatogram with a
retention time of at about 17.3 min by co-injection with an authentic standard (3R,3'R)-
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zeaxanthin (RRZ). It is concluded that the first peak was SSZ. The retention times of SSZ
and RSZ were 13.8 min and 15.9 min, respectively on chiral column. The zeaxanthin
racemic mixtures were used as a standard to identify zeaxanthin stereoisomers isolated
from retinal tissue.
The chiral normal-phase chromatogram of zeaxanthin racemic
mixture
RSZ
4.00E-04
3.00E-04
SSZ
2.00E-04
RRZ
1.00E-04 Lutein
0.00E+00
-1.00E-04
-2.00E-04
-3.00E-04 '' ' ''' ' '
0 2 4 6 8 10 12 14 16 18 20 22 24
Minutes
Figure 3.5 The chromatogram showing the separation of a sample which also
contained a small amount of lutein
2.7 Reversed-phase HPLC conditions
Analysis of all extracted carotenoids from retina samples were conducted on
reversed-phase HPLC system (LDC/Milton Roy solvent delivery system) which was
coupled to an UV-Visible detector set at 450 nm. The column used was a 150 X 4.6 mm
C18 column packed with 3 pm Ultracarb ODS (Phenomenex) and was protected with a
C18 Phenomenex guard cartridge. Separation was achieved with a mobile phase of 85%
acetonitrile and 15% methanol, with 0.1% (V/V) of triethylamine added to inhibit
degradation of carotenoids during elution. The flow rate was 1.0 ml/min.
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2.8 Normal-phase HPLC conditions
Analysis of all zeaxanthin collected from retina samples were conducted on a
Waters 2690 separation module HPLC with a Waters 486 UV tunable detector set at 450
nm and photodiode array detector set from 300 nm to 600 nm. The data was stored and
processed using the MilleniumTM software. The column used was a 250 X 4.6 mm C18
column.
In order to achieve the best resolution of the zeaxanthin stereoisomers, a very
specific composition of mobile phase was needed. Based on Johnson's work32, we
conducted a investigation to optimize the solvent conditions needed to separate the
zeaxanthin stereoisomers. It was determined that a composition of the mobile phase
containing 90% hexane and 10% isopropanol, always with 0.1% (V/V) of triethylamine
added to inhibit degradation of carotenoids during elution result in the separation of the
zeaxanthin stereoisomers. The flow rate used for all separations was 0.8 min/ml. The
solvent composition was varied from 90% hexane to 94% hexane and the resolution of
the stereoisomers was determined using the following equation:47
R= 2[(tR )B-(tR )A
WA+ WB
Where (tR)A and (tR)B are retention time of each peak, and wA and wB are width of each
peak, Figure 3.6.
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Figure 3.6 Calculation of the resolution of a peaks in the chiral column
chromatography47
TABLE 3.1 Resolution of zeaxanthin stereoisomers as a function of solvent
composition
Composition of Resolution Resolution Resolution Elution
mobile phase RSZ RRZ of RRZ & L time (mm)
90% H* and 10% I** 1.9 1.33 2.47 12.45
91% H* and 9% I** 2.01 1.58 2.56 14.78
92% H* and 8% I** 2.51 1.9 2.92 17.31
93% H* and 7% I** 2.27 1.75 2.08 21.73
94% H* and 6% I** 2.7 2.51 2.42 28.69
Note: * H: Hexane; ** I: Isopropanol; *** Mobile phase is always under the isocratic
composition with 0.1% (V/V) of triethylamine to prevent the degradation of carotenoids
during elution; Temperature range of 22 C-25 C.
The optimized solvent composition to separate zeaxanthin stereoisomers was
determined to be 92% hexane and 8% isopropanol with 0.1% (V/V) of triethylamine with
a flow rated of 0.8 ml/min. This composition of mobile phase gives a good resolution of
zeaxanthin stereoisomers while keeping the elution time within acceptable limits.
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2.8 Statistical Analysis
A linear regression analysis was used to test for the association between age and
the amount of lutein, meso-zeaxanthin, and zeaxanthin. F tests were used to determine the
mean xanthophyll concentration in different sections of neonate and adult primate retinas.
Independent t tests were used to determine the effects that age and distribution
had on carotenoid concentration. Results were considered statistically significant at P<
0.05. The Statistical Package for the Social Science (SSPS), version 14.0 was used for all
the statistical analyses in this study.
3. Result and Discussion
The amounts of the carotenoids extracted from retina tissue samples are reported
in nanograms. The calculation is based on Beer's law.
A=cbc
Where A is absorption, F is molar extinction coefficient, b is the pathlength of the cell,
and C is the concentration of the analyte. The extinction coefficient of the internal
standard and lutein are identical at all wavelengths because of the shared chromophore.
The wavelength of detection was selected so that the extinction coefficient of zeaxanthin
was also identical within precision of experimental error. Therefore, we can determine
the amount of carotenoid present in our samples using equation 3.1
MA AAX MMPrL eqn 3.1
MPrL
MA is the amount of the carotenoid. MMPrL is the amount of the internal standard, MPrL.
AA is the peak area of the carotenoid obtained from the chromatogram. AMPrL is the peak
area of the internal standard, MPrL.
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The masses of zeaxanthin and lutein in each sample were determined from their
peak areas relative to that of the internal standard, the mass of which was known. As
stated above, the internal standard, lutein and zeaxanthin all have the same absorption
coefficient at the wavelength of analysis.
The reversed-phase chromatogram of a retina extract is shown in Figure 3.7, and
reveals three dominant peaks, in addition to the internal standard (IS). All of these are
carotenoids with absorption maxima at 450 nm. The most prominent 2 peaks (labeled
Peak 2 and Peak 3) have retention times identical to lutein and zeaxanthin, as shown by
the standards run in Figure 3.6 Peak 1 in Figure 3.7 is much more prominent on analyses
of the retina than of the xanthophylls and attributed to retinal, 15-apo-p-carotenal, that
was extracted from the retina.50 Satellite peaks 4 and 5 are oxo-lutein and zeaxanthin cis
isomer, respectively. After the elution of the internal standard, no significant peaks were
detected.
The reversed phase chromatogram of the neonate primate retina
8000 -Peak 
3
7000 Peak 2
Peak 1
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-Peak 5
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Minutes
Figure 3.7 An example chromatogram showing the carotenoids from a primate retina
using a reversed-phase chromatography. Peak 1, retinal (Vitamin A); Peak 2, lutein; Peak
3, zeaxanthin; Peak 4, oxo-lutein; Peak 5, cis isomer; IS, internal standard, mono-propyl
lutein and its internal standard. 50
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Figure 3.8 Lutein and zeaxanthin standards in reversed-phase chromatogram
(150 mm x 4.6 mm)
The chiral normal-phase chromatogram of the macular zeaxanthin after collection
from the reversed-phases separation is shown in Figure 3.8. This chromatogram reveals
three dominant peaks, in addition to lutein. The first three peaks have been identified as
SSZ, RSZ, and RRZ by comparison of chromatogram of zeaxanthin racemic mixture as
previously described.
S,S-zeaxanthin was not observed in all retina samples but was clearly present in a
few. S,S-zeaxanthin was found in detectable quantities in both neonate and adult retinas
but when detectable amounts of SSZ were observed it was always present as a relatively
small proportion of the total zeaxanthin.
During our studies, the zeaxanthin collected during reversed-phase
chromatography from the inner, medial, and outer regions for the individual sample were
subsequently run on a chiral, normal-phase column to provide a measure of the
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zeaxanthin stereoisomer composition. Table 3.2 shows the detailed data of carotenoids
content present in the pooled sample.
A The chiral normal-phase chromatogram of neonate retina
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B the chiral normal-phase chromatogram of adult retina
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Figure 3.9 HPLC chromatograms, obtained with a chiral normal-phase column, of
macular zeaxanthin A) from analysis of single neonate retina, and B) from analysis of a
single adult primate retina. In order of elution, the peaks are (3S,3'S)-zeaxanthin (SSZ),
meso-zeaxanthin (RSZ), zeaxanthin (RRZ), and lutein (L).
64
During our studies, the zeaxanthin collected during reversed-phase
chromatography from the inner, medial, and outer regions for the individual sample were
subsequently run on a chiral, normal-phase column to provide a measure of the
zeaxanthin stereoisomer composition. Table 3.2 shows the detailed data of carotenoids
content present in the pooled sample.
For each eye that was analyzed individually, the total mass of total zeaxanthin
stereoisomers, ZT, in inner, medial, or outer tissue samples was determined from the
reversed-phase chromatogram by comparison to the internal standard. A similar
calculation gave the mass of L. (A linear relationship between peak area and the mass of
L, ZT and standard was determined by independent measurements). Using the relative
peak areas obtained from the chiral normal-phase chromatograms, it was possible to
confirm the mass of ZT among the zeaxanthin stereoisomers.
For adult retinas, samples are only analyzed by reversed-phase HPLC. In 2 mm
punches, the concentration of L ranged from 8.001-18.848 ng/mm 2, and Z is ranged from
24.432-92.098 ng/mm 2. In 4 mm punches, the concentration of L ranged from 5.806-
19.867 ng/mm2 and Z ranged from 8.728-22.345 ng/mm 2. In 8 mm punches, the
concentration of L ranged from 6.210-11.869 ng/mm 2 and Z ranged from 4.076-11.869
ng/mm2.
For fetus and neonate retinas, samples are analyzed by both reversed-phase and
normal-phase chiral HPLC. In 2 mm punches, the concentration of L ranged from 0.037-
2.462 ng/mm 2, RRZ ranged from 0-1.357 ng/mm 2, and RSZ ranged from 0.021-2.024
ng/mm2. SSZ is present in only 4 samples ranged from 0.01-0.25 ng/mm2. In 4 mm
punches, the concentration of L ranged from 0.027-0.641 ng/mm2, RRZ ranged from
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0-0.251 ng/mm2 , and RSZ ranged from 0-0.256 ng/mm2 . SSZ is only present in 2 samples
(0.009 ng/mm 2). In 8mm punches, the concentration of L ranged from 0.003-0.242
ng/mm 2, RRZ ranged from 0.006-0.109 ng/mm 2, and RSZ ranged from 0-0.021 ng/mm 2.
SSZ is only present in 1 sample (0.009 ng/mm 2).
3.1 Individual Retinal Distribution:
For a single neonate retina, chromatograms of extracts from the central disk
('inner') and two concentric annuli of tissue ('medial' and 'outer') consistently displayed
the trend, previously observed,48' 49 of an increasing lutein (L) : zeaxanthin (ZT) ratio with
increasing distance from the fovea. This is apparent from the sample chromatograms, the
result of analysis of different sections obtained from a single eye, shown in Figure 3.10.
For the inner, medial, and outer regions, the average ZT:L ratios obtained using
individuals eyes were 0.84 0.10, 0.67 0.06, 0.49 0.18, respectively.
Figure 3.10 shows the comparison of the HPLC chromatogram from the three
sections of a neonate retina. With increasing eccentricity, there is a clear change in the
proportions and amounts of the two xanthopylls, lutein and zeaxanthin. In Figure 3.10A
ZT is present in greater amounts than lutein whereas in 3.1OB L and ZT are approximately
equal in abundance and in 3.1 OC lutein in the dominant carotenoid.
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A e reversed-phase chormatogram of 2mm punch in the neonate retina
MPrL (IS)
6000 ZT
5000
4000 L
3000
a 2000
1000
0
0 2 4 6 8 10 12 14 16
Minutes
BThe reversed-phase chromatogram of 4mm punch in neonate retina
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Figure 3.10 HPLC chromatograms obtained with a reversed-phase column of
carotenoids. These were obtained from the three different regions of a single primate
retina. In order of elution, the carotenoids are lutein (L), zeaxanthin (Z1 ), and internal
standard (IS)
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A The chiral normal-phase chromatogram of 2 mm punch of neonate
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Figure 3.11 HPLC chromatograms obtained with a chiral, normal-phase column of
macular zeaxanthin. These were obtained from the three different regions of a single
primate retina, A) inner, B) medial, and C) outer retinal sections. In order of elution, the
compounds are meso-zeaxanthin (RSZ), R,R-zeaxanthin (RRZ), and lutein (L). In (C)
the small peak did not elute at the characteristic retention time and the amount typically
detected was much less than in the other sections
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The zeaxanthin collected during reversed-phase chromatography from the inner,
medial, and outer regions for the pooled samples subsequently yielded the chiral column
chromatograms, shown in Figure 3.11. Figure 3.11 A demonstrates the presence of RSZ
and RRZ in the inner 2 mm retina sections, and both of them were found to be present in
comparable quantities. In the 4 mm retina sections, RSZ and RRZ were found to present
in much lower amounts than in 2 mm retina sections. Observation of detectable amounts
of RSZ in 8 mm section was rare, see Figure 3.11 C. By comparing the retention times of
RRZ in Figure 3.11 C, A, B, and C chromatograms, we can see that the retention times
can vary by minutes. This is because of the sensitivity of the retention time on the chiral
column to different temperatures in the lab from day to day. Standard samples were run
on each day to provide reference retention times. In Figure 3.11 A, lutein is observed in
the chromatograms because collection of the zeaxanthin peak from the reversed-phase
column was started prior to the completed elution of lutein.
Table 3.3.1, Table 3.3.2, and Table 3.3.3 list the masses of L, ZT, RRZ, RSZ, SSZ
for distribution studies for neonate retinas. These results will be discussed individually as
part of the discussion of the effect of age on carotenoid levels (see below). For neonate
primate retinas, the average RSZ:ZT ratios of inner, medial, and outer regions obtained
using individuals eyes were 0.49 0.15, 0.26 0.13, 0.04 0.12 respectively, see Table
3.3.1 and 3.3.2. The average RSZ:L ratios of inner, medial, and outer regions for
individuals were 0.24 0.07, 0.20 0.12, 0.05 0.04, respectively, see Table 3.3.1 and 3.3.2.
In computing such averages, here and elsewhere, left and right eye data for a primate,
where available, were averaged. The amounts of the different carotenoids present in the
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inner, medial, and outer regions in moles/mm2 are shown in the Table 3.2.1, 3.3.2, and
3.3.3.
TABLE 3.3.1 Mean ( SD) carotenoid concentrations in retina sections, on 2 mm and
4 mm
Carotenoids 2 mm punches 4 mm punches P-value
Lutein (L), ng/mm2 0.64 0.13 0.24 0.03 <0.001
Total zeaxanthin (ZT), ng/mm2 0.66 0.19 0.15 0.02 <0.001
ZT/L 0.84 0.10 0.67 0.06 0.049
Xanthophylls, ng/mm2 0.50 0.07 0.39 0.05 NS
Meso-zeaxanthin (RSZ), 0.29 0.11 0.04 0.02 <0.001
ng/mm2
R,R-zeaxanthin (RRZ)' 0.53 0.14 0.14 0.02 <0.001
ng/mm2
Z/RRZ 0.49 0.15 0.26 0.13 NS
Z/L 0.24 0.07 0.20 0.12 NS
N 17 22 N\A
P-value tests the statistical difference between carotenoid concentrations at 2 mm
punch and 4 mm punch retinas
NS= Not significant
Results were considered significant if P<0.05
N=Total number of samples
TABLE 3.3.2 Mean ( SD) carotenoid concentrations in retina sections,
4 mm and 8 mm
Carotenoids 4 mm punches 8 mm punches P-value
Lutein (L), ng/mm 2  0.24+0.03 0.08 0.01 <0.001
Total zeaxanthin (ZT), ng/mm2 0.15 0.02 0.04 0.01 <0.001
ZT/L 0.67 0.06 0.49 0.18 0.026
Xanthophylls, ng/mm2 0.39 0.05 0.12 0.02 <0.001
Meso-zeaxanthin (RSZ), ng/mm 2  0.04 0.02 0.002 0.003 0.002
R,R-zeaxanthin (RRZ), ng/mm2 0.14 0.02 0.05 0.01 0.001
RSZ/RRZ 0.26 0.13 0.04 0.12 0.12
RSZ/L 0.20 0.12 0.05 0.04 NS
N 22 20 N/A
P-value tests the statistical difference between carotenoid concentrations at 4 mm
punch and 8 mm punch retinas
NS= Not significant
Results were considered significant if P<0.05
N=Total number of samples
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TABLE 3.3.3 Mean ( SD) carotenoid concentrations in retina sections on
2 mm and 8 mm
Carotenoids 2 mm punches 8 mm punches P-value
Lutein (L), ng/mm 2  0.64 0.13 0.08 0.01 <0.001
Total zeaxanthin (ZT), ng/mm 2  0.66 0.19 0.04 0.01 <0.001
ZT/L 0.84 0.10 0.49 0.18 <0.001
Xanthophylls, ng/mm 2  0.50 0.07 0.12 0.02 0.001
Meso-zeaxanthin (RSZ),
ng/mm 2  0.29 0.11 0.002 0.003 <0.001
R,R-zeaxanthin (RRZ),
ng/mm 2  0.53 0.14 0.05 0.01 <0.001
RSZ/RRZ 0.49 0.15 0.04 0.12 <0.001
RSZ/L 0.24 0.07 0.05 0.04 0.013
N 17 20 N/A
P-value tests the statistical difference between carotenoid concentrations at 2 mm punch
and 8 mm punch retinas
NS= Not significant
Results were considered significant if P<0.05
N= Total number of samples
The means of the carotenoid concentration in the retina were compared for inner,
medial, and outer punches. Table 3.3.1 compares the mean L, RSZ, and RRZ in 2 mm
and 4 mm punches. Table 3.3.2 compares the mean for each carotenoid in 4 mm and
8 mm punches. Table 3.3.3 compares the mean for each carotenoid in 2 mm and 8 mm
punches. Most of the differences observed between the 2 mm, 4 mm, and 8 mm punches
were statistically significant. Lutein is consistently present in greatest amounts in the
central 2 mm of the retina (P<0.001) for these neonate retinas. Similarly ZT is also
present is greater quantities in the central 2 mm (P<0.001) than in the 4 or 8 mm tissue
sections. A statistical comparison of the (RRZ+RSZ)/L ratio of the 2 mm and 4 mm
sections shows that there is a significant change between the 2 sections, and the
comparison of the (RRZ+RSZ)/L ratio of the 4 mm and 8 mm sections also shows that
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there is a significant change between. The two stereoisomers of zeaxanthin are always
present in greatest amounts in the central 2 mm region.
Apart from minor carotenoid metabolites identified as oxo-lutein and carotenoid
cis isomers, 50 zeaxanthin and lutein are the only known carotenoids observed in the
retinal tissues. There is a recent report that small amounts of 3'-methoxyzeaxanthin are
observed in human retinas.5 1 These results show that carotenoids are selectively
accumulated in central portion of a retina. The ratio of RSZ/L and ZT/L increased with
increasing distance from fovea of the retina. This trend is illustrated graphically in Figure
3.12. The result is essentially consistent with Johnson's reports that L is the precursor of
RSZ and it occurs in 2 mm retina sections.32
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Figure 3.12 The ratio of meso-zeaxanthin to lutein (vertical) and ZT to lutein
(horizontal) for different sections of retina tissue.
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3.2 Age Effects
In this study, 21 retinas form new born monkeys, fetus to 7 months in age, 3
young monkeys from 12 months to 19 months, and 8 adult monkeys from 6 years old to
15 years old were analyzed. For approximately 80% of the monkeys the results were
obtained for both eyes and the average value was recorded. For the remainder, reliable
data were obtained only for one eye.
Based on previous work, carotenoids are known to selectively accumulate in the
central portion of a retina.2 ' In this study, the relationship between age and amount of
each carotenoid in this study was limited to 2 mm punches of retinas. From Figure 3.13,
the amounts of lutein, see Figure 3.13A, RSZ Figure 3.13B, RRZ, see Figure 3.13C in
2 mm punches increased significantly with age. All of these increase as the age increases.
From Figure 3.14, the ratios of RSZ/L and ZT/L in 2 mm punches were all found to vary
significantly with age. Meanwhile, the ratio of RSZ/L, see Figure 3.14A for animals
younger than 7 months was consistently less than 0.3, average value 0.01 0.11 for
younger animals and 0.06 0.31 for older animals. And ZT/L, see Figure 3.14B for
animals younger than 7 months was consistently less than 1.00, average value 0.64 0.08
for younger animals and 1.70 0.42 for older animals.
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Figure 3.13 Effect of age on the amounts of for L, RSZ, and RRZ in neonate primate
retinas
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Figure 3.14 Effect of age on the ZT/L, and RSZ/L ratio in neonate retinas
The combined masses of xanthophylls (zeaxanthin and lutein) in the whole retinas
were insignificantly different between new born and adult monkeys, as illustrated in
Figure 3.15. However, the ZT/L ratio showed a significant variation (P=0.000) between
new born and adult monkeys. This can be seen in Figure 3.16, where the average result
and associated standard deviations are plotted for new born and adult monkeys. For the
new born monkeys, the dominant pigment was consistently lutein, while the dominant
pigment was zeaxanthin in retinas of adult monkey. A value of 1.0 is the boundary of
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between ZT/L ratio of new born and adult monkeys. This can be seen in TABLE 3.4. The
results obtained from new-born monkeys, where the average zeaxanthin: lutein ratio was
0.60 0.08 is compared with a value of 2.05 0.44 for adult monkeys.
Xanthophylls
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Figure 3.15 Effect of age on the total mass of xanthophylls in new born and adult primate
retinas
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Figure 3.16 Effect of age on the total mass of the ZT/lutein ratio between new born and
adult primate retinas
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TABLE 3.4 Mean ( SD) between carotenoid concentrations at new born and adult retinas
Carotenoids New born Adult P-value
monkeys monkeys
Lutein (L), ng/mm 2  7.65 1.28 4.53 0.65 0.003
Zeaxanthin (ZT), ng/mm 2  4.74 0.98 7.84 3.86 NS
Xanthophylls, ng/mm 2  12.39 2.15 12.37 1.38 NS
Z 1/L 0.64 0.08 2.05 0.44 <0.001
P-value tests the statistical difference between carotenoid concentrations at new born
and adult monkey retinas
NS= Not significant
Results were considered significant if P<0.05
4. Conclusion
Both neonate and adult primate retinas were investigated in this study. For adult
primate eyes, generally, the amount of carotenoid observed were low compared to those
found in human, averaging 12.4 3.0 ng of total carotenoid. This is essentially
consistent with results reported by Handelman et. al.3 1 in which they measured an
average value of 12.4 5.7 ng for the retinal carotenoid content. In our study, we have
found the average of total ZT to lutein ratio is 2.0 1.0 as compared to 1.4 0.5 ng
observed by Handelman et. al.3 ' For neonate retinas, the average of zeaxanthin to lutein
ratio is 0.6 0.2 which is lower than that found by both Handelman et. al. and the adult
macaque retina study reported here. 3' This result is consistent with the prediction of
Bone and Landrum2 1 and the observation of Johnson et. al.32 that lutein is the precursor
of meso-zeaxanthin (RSZ); we expect that meso-zeaxanthin (RSZ) must be present in
lower amounts in young animals since it is a metabolic product.
For single retinas, the amount and distribution of lutein and zeaxanthin
stereoisomers in neonate primate eyes was studied. The results show that the amounts of
lutein, meso-zeaxanthin, and R,R-zeaxanthin in 2 mm punches are significantly greater
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than in 4 mm annuli (P<0.0001), and the amounts in 4 mm annuli are significantly
greater than in 8 mm annuli (P<0.002). The ratios of Z1 /L and RSZ/L dramatically
dropped as the annuli increased. For the age study, the amounts of L, RSZ, and RRZ in
2 mm punches were all found to vary significantly with age (P<0.003). The ratios of
RSZ/L and Z1/L in 2 mm punches increased significantly with age (P<0.001). A t-test,
was employed in comparing carotenoids and their ratios between new born
(fetus-7months old) primate retinas and adult (6yrs-10yrs old) primate retinas. The
results show that the ratio of ZT/L in adult primate retinas was significantly greater than
the ratio in the new born primate retinas, see Figure 3.16.
These data are the first to define in detail the developmental course of macular
pigment in the non-human primate retina. The increase in the RSZ/L ratio with age is
consistent with a pathway in which L is converted to RSZ. RSZ was not detected in the
retinas of macaques younger than 25 days, indicating that retinal conversion of L to
RSZ begins soon after birth and increases in efficiency with the development of the
retina. The decrease in the RSZ/L ratio with eccentrically indicates that the conversion
primarily occurs in central portion. SSZ was present in both neonate and adult retinas,
but only a few samples; the presence of SSZ is evidence that the physiology of
carotenoids in the primate retina involves complex transformations about which we
have little knowledge.
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Chapter IV CONCLUSIONS
1. Identification of P,P-carotene-3,3'-dione
It has been hypothesized that PP-carotene-3,3'-dione is a metabolite of
zeaxanthin in biological systems. PP-carotene-3,3'-dione is also a suggested intermediate
product formed during the 2 step reduction of rhodoxanthin to produce the zeaxanthin
stereoisomers. In vitro oxidation of zeaxanthin with MnO 2 in acetone produces three
components. They have identified as all-trans rhodoxanthin and its two cis-isomers. All
of these are reduced by Zn/HOAc in CHC 2 to produce an intermediate product that has
been suggested to be P,P-carotene-3,3'-dione.52 This compound is fairly reactive and only
limited amounts of it can be obtained in sufficiently pure form to enable spectroscopic
studies needed to confirm the structure. In our study we have attempted to provide a
complete characterization of the structure of this intermediate product. In this effort, we
have used both analytical and spectroscopic methods including, IR, UV/Vis, MS, 'H-
NMR, and HPLC to characterize its structure.
In summary, we have been able to demonstrate that the reduction of rhodoxanthin
produces a product whose spectroscopic properties are completely consistent with an
assignment as PP-carotene-3,3'-dione. The data obtained rule out the presence of the
tautomer, s,s-carotene-3,3'-dione. j,P-carotene-3,3'-dione was found to rapidly react
with atmospheric oxygen, even at low temperatures (4 C) to revert to rhodoxanthin. The
reactivity of this diketone in vitro makes its detection as a metabolite unlikely and its
tendency to oxidize to form rhodoxanthin, which is not observed, further supports the
conclusion that P,P-carotene-3,3'-dione is not formed from zeaxanthin in vivo. The in
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vivo metabolic products formed from zeaxanthin remain incompletely understood but this
work has shown that the probability that hydroxyl group oxidation to form a diketone is
unlikely.
These results are significant because they demonstrate that oxidation of the
hydroxyl groups of zeaxanthin to produce P,P-carotene-3,3'-dione, while an apparently
reasonable chemical outcome, is not consistent with the chemistry of this molecule or the
absence of rhodoxanthin in human serum as a secondary metabolite. The characterization
of PP-carotene-3,3'-dione increments our understanding of the carotenoids and their
chemistry. This thesis presents the first definitive study of this molecule and its
spectroscopic properties.
2. Changes in Carotenoid Stereoisomers in the Non-Human Primate Retina with
Age
The presence of high concentrations of carotenoids in the central retina of adult
humans and primates has been a topic of interest for researchers in the field of vision for
some time. Very little work has been carried out on the carotenoid content of the retina
in the young eye and there is virtually nothing known about the developmental steps that
lead to the deposition of the carotenoid mixtures observed in older individuals. It is well
known that meso-zeaxanthin is found only in the retina and is metabolite of lutein and
some early research showed that the retinas of the very young humans have lower levels
of pigment overall and that the ratio of zeaxanthin to lutein in these subjects was lower
than in the adult. In this study we have had the opportunity to study neonatal retinas from
macaque monkeys and to analyze amounts of carotenoids found in these tissues.
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We have applied the use of chiral column HPLC to the analysis of retinal sections
of neonatal macaque retinas providing the first data on the developmental changes that
characterize the macular pigment in non-human primates. Our results obtained from the
study of 32 retinas demonstrates that the neonate retina is indeed deficient in meso-
zeaxanthin as compared to adult retinas and that the proportion of this carotenoid
increases with age reaching an adult ratio during the first year of life. These data lend
further evidence of the meso-zeaxanthin is a metabolic product formed from lutein in the
retina. The steady increase in the proportion of meso-zeaxanthin present in the neonate
with increasing age is consistent with an enzymatic mechanism that becomes functional
shortly after birth as the retina matures. We have been unable to detect meso-zeaxanthin
in the retina prior to one month following birth.
The stereisomer S,S-zeaxanthin was detectable in the retinas of a few young
monkeys, but not consistently. The metabolic pathway by which this isomer could
readily form is not understood. It is clear from these data that the pathway of S,S-
zeaxanthin formation must be distinctly different from that of meso-zeaxanthin. The
formation of S,S-zeaxanthin requires a change in the absolute configuration in one
stereocenter if the precursor molecule is lutein and would require a change in two if
zeaxanthin is the precursor. A potential chemical pathway for the formation of S,S-
zeaxanthin would be the enzymatic reduction of PP-carotene-3,3'-dione, however our
work on this molecule suggests this is unlikely. The nature of the pathway by which S,S-
zeaxanthin forms in the retina remains a unresolved question.
Carotenoid metabolism in the retina changes during the first months of life as the
retina itself undergoes developmental changes. Further study of the neonate retina and
82
the compositional changes that characterize the macular pigment in this period would be
helpful to extending our understanding functions of carotenoids in the eye.
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